Supplementary data for the manuscript: LINC00886 negatively regulates malignancy in anaplastic thyroid cancer

Table S1. The information of patients and samples from the FUSCC Table S2. Sequences for lncRNA smart silencer, siRNA and the primers Table S3. RNA sequencing data of LINC00886 knockdown in CAL-62 Table S4. Antibodies used in this study Table S5. The 65 differential lncRNAs screened out in DDTC Table S6. The top 10 lncRNAs deregulated in DDTC Table S7. GSEA of LINC00886 knockdown, ATC and PTC Table S8. Potential LINC00886-interacting proteins screened out by RNA pulldown assays Fig. S1 Clinicopathological associations of LINC00886 expression in thyroid cancer Fig. S2 The basic feature of LINC00886 and clinicopathological associations in ATC Fig. S3 The biological signaling pathways identified by GSEA in PTC and ATC